Search research articles
Contact Us
Filters
Showing results (81-90 of 115) with videos related to
Page
of 12
Sort By:
The Journal of Urology
|
June 8, 2022
Surveillance after Complete Response to First-Line Chemotherapy in Patients with Metastatic Nonseminomatous Germ Cell Tumor
Jennifer M King, Sandra Althouse, Clint Cary, et al.
The Journal of Urology
|
June 22, 2014
Management of germ cell tumors with somatic type malignancy: pathological features, prognostic factors and survival outcomes
Kevin R Rice, Martin J Magers, Stephen D W Beck, et al.
The Journal of Urology
|
September 28, 2002
Teratoma in the orchiectomy specimen and volume of metastasis are predictors of retroperitoneal teratoma in post-chemotherapy nonseminomatous testis cancer
Stephen D W Beck, Richard S Foster, Richard Bihrle, et al.
The Journal of Urology
|
July 21, 2021
Percentage of Teratoma in Orchiectomy and Risk of Retroperitoneal Teratoma at the Time of Postchemotherapy Retroperitoneal Lymph Node Dissection in Germ Cell Tumors
Adam C Calaway, Sean Q Kern, David Crook, et al.
Cancer
|
March 26, 2003
Anatomic distribution of periprostatic adipose tissue: a mapping study of 100 radical prostatectomy specimens
Heng Hong, Michael O Koch, Richard S Foster, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 6, 2020
Prognostic Value of Teratoma in Primary Tumor and Postchemotherapy Retroperitoneal Lymph Node Dissection Specimens in Patients With Metastatic Germ Cell Tumor
Fadi Taza, Michal Chovanec, Anna Snavely, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 8, 2022
Primary Retroperitoneal Lymph Node Dissection for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumor-N1, N2, and N3 Disease: Is Adjuvant Chemotherapy Necessary?
Isamu Tachibana, Sean Q Kern, Antoin Douglawi, et al.
European Urology
|
October 4, 2022
Reply to Alireza Ghoreifi and Hooman Djaladat's Letter to the Editor re: Isamu Tachibana, Sean Q. Kern, Antoin Douglawi, et al. Primary Retroperitoneal Lymph Node Dissection for Patients with Pathologic Stage II Nonseminomatous Germ Cell Tumor-N1, N2, and N3 Disease: Is Adjuvant Chemotherapy Necessary? J Clin Oncol. In press. https://doi.org/10.1200/JCO.22.00118: Is Retroperitoneal Lymph Node Dissection Without Adjuvant Chemotherapy Enough for All Patients with Pathologic Stage II Nonseminoma Germ Cell Tumor?
Isamu Tachibana, Sean Q Kern, Antoin Douglawi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2004
Gene expression profiling of early- and late-relapse nonseminomatous germ cell tumor and primitive neuroectodermal tumor of the testis
Jun Sugimura, Richard S Foster, Oscar W Cummings, et al.
Urology
|
March 4, 2014
Plasmacytoid bladder cancer: variant histology with aggressive behavior and a new mode of invasion along fascial planes
Hristos Z Kaimakliotis, M Francesca Monn, Liang Cheng, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 115) with videos related to
Sort By:
Page
of 12
The Journal of Urology
|
June 8, 2022
Surveillance after Complete Response to First-Line Chemotherapy in Patients with Metastatic Nonseminomatous Germ Cell Tumor
Jennifer M King, Sandra Althouse, Clint Cary, et al.
The Journal of Urology
|
June 22, 2014
Management of germ cell tumors with somatic type malignancy: pathological features, prognostic factors and survival outcomes
Kevin R Rice, Martin J Magers, Stephen D W Beck, et al.
The Journal of Urology
|
September 28, 2002
Teratoma in the orchiectomy specimen and volume of metastasis are predictors of retroperitoneal teratoma in post-chemotherapy nonseminomatous testis cancer
Stephen D W Beck, Richard S Foster, Richard Bihrle, et al.
The Journal of Urology
|
July 21, 2021
Percentage of Teratoma in Orchiectomy and Risk of Retroperitoneal Teratoma at the Time of Postchemotherapy Retroperitoneal Lymph Node Dissection in Germ Cell Tumors
Adam C Calaway, Sean Q Kern, David Crook, et al.
Cancer
|
March 26, 2003
Anatomic distribution of periprostatic adipose tissue: a mapping study of 100 radical prostatectomy specimens
Heng Hong, Michael O Koch, Richard S Foster, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 6, 2020
Prognostic Value of Teratoma in Primary Tumor and Postchemotherapy Retroperitoneal Lymph Node Dissection Specimens in Patients With Metastatic Germ Cell Tumor
Fadi Taza, Michal Chovanec, Anna Snavely, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 8, 2022
Primary Retroperitoneal Lymph Node Dissection for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumor-N1, N2, and N3 Disease: Is Adjuvant Chemotherapy Necessary?
Isamu Tachibana, Sean Q Kern, Antoin Douglawi, et al.
European Urology
|
October 4, 2022
Reply to Alireza Ghoreifi and Hooman Djaladat's Letter to the Editor re: Isamu Tachibana, Sean Q. Kern, Antoin Douglawi, et al. Primary Retroperitoneal Lymph Node Dissection for Patients with Pathologic Stage II Nonseminomatous Germ Cell Tumor-N1, N2, and N3 Disease: Is Adjuvant Chemotherapy Necessary? J Clin Oncol. In press. https://doi.org/10.1200/JCO.22.00118: Is Retroperitoneal Lymph Node Dissection Without Adjuvant Chemotherapy Enough for All Patients with Pathologic Stage II Nonseminoma Germ Cell Tumor?
Isamu Tachibana, Sean Q Kern, Antoin Douglawi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2004
Gene expression profiling of early- and late-relapse nonseminomatous germ cell tumor and primitive neuroectodermal tumor of the testis
Jun Sugimura, Richard S Foster, Oscar W Cummings, et al.
Urology
|
March 4, 2014
Plasmacytoid bladder cancer: variant histology with aggressive behavior and a new mode of invasion along fascial planes
Hristos Z Kaimakliotis, M Francesca Monn, Liang Cheng, et al.
Page
of 12